A Harvard Neuroscientist Says We’re Medicating Normal Human Behavior | Dr. Adam Omary EP 237
In a Nutshell
Dr. Adam Omary argues that the massive rise in gender dysphoria—especially among teenage girls—and mental health diagnoses stems from overdiagnosis, social contagion, and financial incentives created by expanded DSM criteria and insurance mandates around 2010, rather than genuine epidemics. He contends that puberty blockers, cross-sex hormones, and widespread SSRI use medicalize normal developmental distress and often worsen outcomes, with weak evidence supporting their benefits and growing evidence of harm including permanent side effects for detransitioners. The solution involves rejecting reflexive medicalization of ordinary behavior, preserving bodily autonomy for informed adults, and prioritizing resilience and addressing root causes over pharmacological intervention.
These notes were generated by AI and may contain inaccuracies.
Dr. Adam Omary is a psychologist and neuroscientist who studied at Harvard, focusing initially on gender dysphoria. Prior to that research, he studied hormones and brain development with emphasis on sex differences during puberty and intersex conditions. His earlier work examined rare intersex conditions, which are mostly genetic anomalies and endocrine disorders resulting in hormone imbalances that can lead to personality differences and, in extreme cases, gender dysphoria.
Intersex conditions exist but occur at very low rates—one in 100,000 people or fewer for any particular condition. These conditions do not represent a third sex; individuals remain genetically male or female with specific anomalies leading to intersex phenotypes. Historically, transgender individuals likely had rare genetic conditions causing them to feel they were in the wrong body. Omary expresses sympathy for these rare cases.
There has been an explosion in gender dysphoria cases over the last decade or two, especially among teenage girls. The gender affirming care protocol involving hormonal and surgical intervention has been a disaster. Omary warned about this outcome during a previous podcast two years prior.
Omary completed his dissertation on what is driving the surge in gender dysphoria cases, particularly among teenage girls. At Harvard, Steven Pinker was the only adviser willing to support this research topic, requiring Omary to switch advisers from his original neuroscience lab.
Sign in to read the full notes
Get access to AI-generated notes, topic timestamps, and more.